BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 26952346)

  • 1. Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery.
    Sujata N; Tobin R; Kaur R; Aneja A; Khanna M; Hanjoora VM
    Int J Gynaecol Obstet; 2016 Jun; 133(3):312-5. PubMed ID: 26952346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic tranexamic acid for reducing intraoperative blood loss during cesarean section in women at high risk of postpartum hemorrhage: A double-blind placebo randomized controlled trial.
    Ortuanya KE; Eleje GU; Ezugwu FO; Odugu BU; Ikechebelu JI; Ugwu EO; Eke AC; Awkadigwe FI; Ezenwaeze MN; Ofor IJ; Okafor CC; Okafor CG
    Womens Health (Lond); 2024; 20():17455057231225311. PubMed ID: 38279808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized placebo-controlled trial of preoperative tranexamic acid among women undergoing elective cesarean delivery.
    Maged AM; Helal OM; Elsherbini MM; Eid MM; Elkomy RO; Dahab S; Elsissy MH
    Int J Gynaecol Obstet; 2015 Dec; 131(3):265-8. PubMed ID: 26341174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial.
    Abdel-Aleem H; Alhusaini TK; Abdel-Aleem MA; Menoufy M; Gülmezoglu AM
    J Matern Fetal Neonatal Med; 2013 Nov; 26(17):1705-9. PubMed ID: 23574458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery.
    Sentilhes L; Sénat MV; Le Lous M; Winer N; Rozenberg P; Kayem G; Verspyck E; Fuchs F; Azria E; Gallot D; Korb D; Desbrière R; Le Ray C; Chauleur C; de Marcillac F; Perrotin F; Parant O; Salomon LJ; Gauchotte E; Bretelle F; Sananès N; Bohec C; Mottet N; Legendre G; Letouzey V; Haddad B; Vardon D; Madar H; Mattuizzi A; Daniel V; Regueme S; Roussillon C; Benard A; Georget A; Darsonval A; Deneux-Tharaux C;
    N Engl J Med; 2021 Apr; 384(17):1623-1634. PubMed ID: 33913639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study protocol. TRAAP - TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial.
    Sentilhes L; Daniel V; Darsonval A; Deruelle P; Vardon D; Perrotin F; Le Ray C; Senat MV; Winer N; Maillard F; Deneux-Tharaux C
    BMC Pregnancy Childbirth; 2015 Jun; 15():135. PubMed ID: 26071040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic and pharmaco-biological, dose-ranging multicentre trial to determine the optimal dose of TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery (TRACES): study protocol for a randomised, double-blind, placebo-controlled trial.
    Bouthors AS; Hennart B; Jeanpierre E; Baptiste AS; Saidi I; Simon E; Lannoy D; Duhamel A; Allorge D; Susen S
    Trials; 2018 Mar; 19(1):148. PubMed ID: 29490682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral uterine artery ligation plus intravenous tranexamic acid during cesarean delivery for placenta previa: a randomized double-blind controlled trial.
    Abbas AM; Shady NW; Sallam HF
    J Gynecol Obstet Hum Reprod; 2019 Feb; 48(2):115-119. PubMed ID: 30412786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic acid for the prevention of blood loss after cesarean section: an updated systematic review and meta-analysis of randomized controlled trials.
    Cheema HA; Ahmad AB; Ehsan M; Shahid A; Ayyan M; Azeem S; Hussain A; Shahid A; Nashwan AJ; Mikuš M; Laganà AS
    Am J Obstet Gynecol MFM; 2023 Aug; 5(8):101049. PubMed ID: 37311484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranexamic acid for cesarean section: a double-blind, placebo-controlled, randomized clinical trial.
    Sentürk MB; Cakmak Y; Yildiz G; Yildiz P
    Arch Gynecol Obstet; 2013 Apr; 287(4):641-5. PubMed ID: 23143410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAnexamic acid in hemorrhagic CESarean section (TRACES) randomized placebo controlled dose-ranging pharmacobiological ancillary trial: study protocol for a randomized controlled trial.
    Ducloy-Bouthors AS; Jeanpierre E; Saidi I; Baptiste AS; Simon E; Lannoy D; Duhamel A; Allorge D; Susen S; Hennart B
    Trials; 2018 Mar; 19(1):149. PubMed ID: 29490690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery.
    Movafegh A; Eslamian L; Dorabadi A
    Int J Gynaecol Obstet; 2011 Dec; 115(3):224-6. PubMed ID: 21872857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAAP2 - TRAnexamic Acid for Preventing postpartum hemorrhage after cesarean delivery: a multicenter randomized, doubleblind, placebo- controlled trial - a study protocol.
    Sentilhes L; Daniel V; Deneux-Tharaux C;
    BMC Pregnancy Childbirth; 2020 Jan; 20(1):63. PubMed ID: 32005192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic Tranexamic Acid in High-Risk Patients Undergoing Cesarean Delivery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Stortroen NE; Tubog TD; Shaffer SK
    AANA J; 2020 Aug; 88(4):273-281. PubMed ID: 32718424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Simonazzi G; Bisulli M; Saccone G; Moro E; Marshall A; Berghella V
    Acta Obstet Gynecol Scand; 2016 Jan; 95(1):28-37. PubMed ID: 26698831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranexamic acid for the prevention of blood loss after cesarean among women with twins: a secondary analysis of the TRAnexamic Acid for Preventing Postpartum Hemorrhage Following a Cesarean Delivery randomized clinical trial.
    Sentilhes L; Madar H; Le Lous M; Sénat MV; Winer N; Rozenberg P; Kayem G; Verspyck E; Fuchs F; Azria E; Gallot D; Korb D; Desbrière R; Le Ray C; Chauleur C; de Marcillac F; Perrotin F; Parant O; Salomon LJ; Gauchotte E; Bretelle F; Sananès N; Bohec C; Mottet N; Legendre G; Letouzey V; Haddad B; Vardon D; Mattuizzi A; Froeliger A; Bouchghoul H; Daniel V; Regueme S; Roussillon C; Georget A; Darsonval A; Benard A; Deneux-Tharaux C;
    Am J Obstet Gynecol; 2022 Dec; 227(6):889.e1-889.e17. PubMed ID: 35724759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual misoprostol as an adjunct to oxytocin during cesarean delivery in women at risk of postpartum hemorrhage.
    Chaudhuri P; Majumdar A
    Int J Gynaecol Obstet; 2015 Jan; 128(1):48-52. PubMed ID: 25277789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic use of tranexamic acid for decreasing the blood loss in elective cesarean section: A placebo-controlled randomized clinical trial.
    Naeiji Z; Delshadiyan N; Saleh S; Moridi A; Rahmati N; Fathi M
    J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101973. PubMed ID: 33221559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tranexamic acid for the prevention of postpartum hemorrhage in women undergoing cesarean delivery: an updated meta-analysis.
    Bellos I; Pergialiotis V
    Am J Obstet Gynecol; 2022 Apr; 226(4):510-523.e22. PubMed ID: 34582795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid for prevention of hemorrhage in elective repeat cesarean delivery-a randomized study.
    Ogunkua OT; Duryea EL; Nelson DB; Eddins MM; Klucsarits SE; McIntire DD; Leveno KJ
    Am J Obstet Gynecol MFM; 2022 Mar; 4(2):100573. PubMed ID: 35038612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.